To further elucidate the effect of TLR4/MyD88/CaMKII signaling pathway in the pathogenesis of electrical remodeling induced by MetS, we treated the H9C2 cells with LPS, the TLR4 agonist. This evidence concerns the gene CAMK2G and metabolic syndrome.